Community collaboration, harm reduction models and policy changes can ease the burden on EMS workers and improve patient ...

Stock analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the specialty ...

Amid current economic uncertainties, investing in defensive stocks appears as your best bet for stability, especially if a ...

After being struck down by winter illness, the BBC's James Gallagher goes in search of ways to boost his immune system.

Up to 11% of infants are born with a condition called tongue-tie where the small band of tissue under the tongue is too short, thick, or tight, limiting the tongue's mobility and preventing proper ...

Four of the five suspects charged in the tortured killing of a Michigan woman and burying her body in the dirt basement of a ...

StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock.

Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...